FdaApplication
ANDA 210811
Identifiers
- fda_app_no: ANDA210811
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LIMITED |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE | 600MG | TABLET |
| DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE | 300MG | TABLET |
2 products